Cite

HARVARD Citation

    Fernanda Amary, M. et al. (n.d.). Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo‐adjuvant chemotherapy. Cancer medicine. pp. 980-987. [Online]. 
  
Back to record